IDO1 and neoplasm: IDO downregulation in A549 cells increased tumor cell sensitivity to low dose (1 microM)(data not shown) and high dose (5 microM) olaparib by 18% (P=1×10−3)(Figure 3A and B and Supplementary Figure 2A).